Molecular Subtypes of Pancreatic Cancer: A Proteomics Approach.

Thakur, Ravi; Singh, Pankaj K

Thakur, Ravi; Singh, Pankaj K.

Afiliación

Thakur R; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska.
Singh PK; Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska. pankaj.singh@unmc.edu.

Clin Cancer Res ; 27(12): 3272-3274, 2021 06 15.

Article en En | MEDLINE | ID: mdl-33853864

ABSTRACT

ABSTRACT

Through molecular subtyping, therapeutic vulnerabilities can be exploited for developing personalized medicine. The real utility of molecular subtyping lies in the clinical translation for disease characterization. Proteomic methods with defined marker sets hold great promise for improving therapy outcomes by improving the speed of predictions for devising treatment strategies.See related article by Son et al., p. 3370.

Asunto(s)

Neoplasias Pancreáticas; Proteómica; Humanos; Neoplasias Pancreáticas/tratamiento farmacológico; Neoplasias Pancreáticas/genética; Medicina de Precisión

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Proteómica Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google